3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignanciesnon-small cell lung carcinomaRecruitingPhase 1 / Phase 22026-07-01NCT05443126
Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKINeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-01-21NCT05601973
NOPE37: Angiogenic Factors for Managing Term PreeclampsiaFemale Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorderRecruitingNot applicable2025-12-11NCT07193680